Skip to content

Efficacy of Mindfulness with State-Trait Anxiety and Emotional Dysregulation in Young Adults

Social Science Review Archives May 7, 2025 DOI: 10.70670/sra.v3i2.652 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pre-post intervention study Peer reviewed
Sample size 12
Population Young adult males and females aged 20-30 with state anxiety and emotional dysregulation in Lahore, Pakistan
Intervention Mindfulness intervention
Duration Fourteen sessions
Measures State-Trait Anxiety Inventory (STAI), Emotion Regulation Questionnaire (ERQ)
Topics Anxiety Meditation
Key points Emotional dysregulation was significantly related to state anxiety. The fourteen-session mindfulness intervention produced only mild, non-significant improvement in state anxiety; the authors attribute this to cultural beliefs about therapy and a preference for quick solutions such as medication.

Abstract

This study aimed to evaluate the effectiveness of mindfulness intervention in reducing state anxiety among young adults with emotional dysregulation in Lahore, Pakistan. A total of 100 young adult males and females aged 20-30 with state anxiety and emotional dysregulation were selected from different segments of life in Lahore. The State-Trait Anxiety Inventory (STAI) and Emotion Regulation Questionnaire (ERQ) were administered to assess anxiety levels and emotional regulation before and after the intervention. Participants (n = 12) scoring in the mild to moderate range on these scales were selected for a fourteen-session mindfulness intervention programmed. Pre-post intervention data was analyzed using IBM SPSS 27, employing correlation analysis, paired sample t-tests, and independent sample t-tests. The analysis revealed a significant relationship between emotional dysregulation and state anxiety. However, post-intervention analysis showed mild improvement in state anxiety levels among participants after the mindfulness intervention. Cultural beliefs towards therapy and a preference for quick solutions, such as medication, were identified as contributing factors to the lack of significant improvement.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Explore topics